[1]葛丽艳,王 琦,朱 宏,等.基于数据挖掘分析GPR35表达对肺腺癌预后的影响[J].医学信息,2018,31(23):86-90,95.[doi:10.3969/j.issn.1006-1959.2018.23.024]
　GE Li-yan,WANG Qi,ZHU Hong,et al.The Effect of GPR35 Expression on Prognosis of Lung Adenocarcinoma was Analyzed Based on Data Mining[J].Journal of Medical Information,2018,31(23):86-90,95.[doi:10.3969/j.issn.1006-1959.2018.23.024]
点击复制

基于数据挖掘分析GPR35表达对肺腺癌预后的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年23期
页码:
86-90,95
栏目:
论著
出版日期:
2018-12-01

文章信息/Info

Title:
The Effect of GPR35 Expression on Prognosis of Lung Adenocarcinoma was Analyzed Based on Data Mining
文章编号:
1006-1959（2018）23-0086-06
作者:
葛丽艳; 王 琦; 朱 宏; 邵雪君; 计雪强
苏州大学附属儿童医院检验科，江苏 苏州 215000
Author(s):
GE Li-yan; WANG Qi; ZHU Hong; SHAO Xue-jun; JI Xue-qiang
Department of Clinical Laboratory,Children's Hospital Affiliated of Suzhou University,Suzhou 215000,Jiangsu,China
关键词:
肺腺癌; GPR35; 数据挖掘; Oncomine 数据库
Keywords:
Lung adenocarcinoma; GPR35; Data mining; Oncomine database
分类号:
R734.2
DOI:
10.3969/j.issn.1006-1959.2018.23.024
文献标志码:
A
摘要:
研究数据挖掘分析GPR35表达对肺腺癌预后的影响，并明晰其参与的分析调控网络。方法 利用Oncomine数据库挖掘GPR35在肺腺癌组织中的表达情况；利用Kaplan-Meier Plotter进行肺腺癌患者生存周期分析；利用Coexpedia数据库分析GPR35参与的分子调控网络。结果 GPR35在人体正常组织中均有表达，其中胰腺组织和骨髓来源的CD33+细胞含量较高。相比于正常肺组织，GPR35基因在肺腺癌组织中呈现高表达，而在肺鳞癌以及大细胞肺癌中，未见明显变化。GPR35基因在肺腺癌组织中，男性患者相对于女性患者呈现高表达，而其表达在StageⅠ和StageⅣ均明显上调，且StageⅣ中GPR35的表达高于其他三期的患者；肺腺癌组织中存在EGFR L858R突变的患者，其GPR35的表达相对于无突变的患者明显上调。GPR35的表达水平对肺腺癌患者的总生存时间有着显著影响。与低表达组相比，GPR35高表达组肺腺癌患者的总存活时间降低（P＜0.05）；GPR35的表达水平对LUSC患者的总生存时间未见显著影响（P＞0.05）。GPR35参与多种肿瘤相关的分子调控网络。结论 大样本数据挖掘能迅速准确地获取肺腺癌组织中GPR35表达的相关信息，为深入研究奠定基础。
Abstract:
Objective The expression of GPR35 has been found in many tissues and cells. However, no systemic research on lung adenocarcinoma was reported. Methods The Oncomine database was used to explore the expression of GPR35 in lung adenocarcinoma tissues. Kaplan-Meier Plotter was used to analyze the life cycle of lung adenocarcinoma patients. The Coexpedia database was used to analyze the molecular regulatory network involved in GPR35. Results GPR35 was expressed in normal human tissues, and the content of CD33+ cells in pancreatic tissue and bone marrow was higher. Compared with normal lung tissue, GPR35 gene showed high expression in lung adenocarcinoma tissues, but no significant changes in lung squamous cell carcinoma and large cell lung cancer. GPR35 gene in lung adenocarcinoma tissues, male patients showed high expression compared with female patients, and its expression was significantly up-regulated in both StageI and Stage IV, and the expression of GPR35 in Stage IV was higher than that in other three stages; the presence of lung adenocarcinoma In patients with the EGFR L858R mutation, the expression of GPR35 was significantly up-regulated relative to patients without mutation. The expression level of GPR35 has a significant effect on the overall survival of patients with lung adenocarcinoma. Compared with the low expression group, the total survival time of patients with GPR35 high expression group was decreased (P<0.05);The expression level of GPR35 had no significant effect on the overall survival time of LUSC patients (P>0.05). GPR35 is involved in a variety of tumor-related molecular regulatory networks. Conclusion Large-scale data mining can quickly and accurately obtain information about the expression of GPR35 in lung adenocarcinoma, which lays a foundation for further research.

参考文献/References:

[1]Sigel RL,Miller KD,Jemal A.Cancer statistics,2018[J].CA Cancer J Clin,2018,68(1):7-30.
[2]Resta F,Masi A,Sili M,et al.Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation[J].Neuropharmacology,2016,108(4):136-143.
[3]Nieto Gutierrez A,McDonald PH.GPCRs:Emerging anti-cancer drug targets[J].Cellular Signalling,2018,41(9):65-74.
[4]Wu TS,Tan CT,Chang CC,et al.B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway[J].Oncogene,2017,36(38):5440.
[5]Zhan X,Wang J,Liu Y,et al.GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli[J].Molecular Cancer,2014,13(4):4.
[6]Cheng Y,Yan Z,Liu Y,et al.Analysis of DNA methylation patterns associated with the gastric cancer genome[J].Oncol Lett,2014,7(4):1021-1026.
[7]Rasanen K,Itkonen O,Koistinen H,et al.Emerging Roles of SPINK1 in Cancer[J].Clin Chem,2016,62(3):449-457.
[8]Hayashi T,Saito T,Fujimura T,et al.Galectin-4,a novel predictor for lymph node metastasis in lung adenocarcinoma[J].PLoS One,2013,8(12):e81883.
[9]Chen WC,Wang CY,Hung YH,et al.Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer[J].PLoS One,2016,11(5):e0155660.

相似文献/References:

[1]刘治利,葛明建.肺部磨玻璃结节的CT特征与治疗策略进展[J].医学信息,2018,31(11):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
　LIU Zhi-li,GE Ming-jian.Advances in CT Features and Treatment Strategies of Pulmonary Ground-glass Nodule[J].Journal of Medical Information,2018,31(23):49.[doi:10.3969/j.issn.1006-1959.2018.11.016]
[2]彭玉龙,张 露,陈荣辉,等.吉西他滨与培美曲塞联合卡铂治疗晚期肺腺癌的临床观察[J].医学信息,2018,31(11):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
　PENG Yu-long,ZHANG Lu,CHEN Rong-hui,et al.Clinical Observation of Gemcitabine and Pemetrexed Combined with Carboplatin in Treatment of Advanced Lung Adenocarcinoma[J].Journal of Medical Information,2018,31(23):124.[doi:10.3969/j.issn.1006-1959.2018.11.039]
[3]刘贤丰,李子俊.恩度联合培美曲塞与顺铂治疗晚期肺腺癌的临床效果观察[J].医学信息,2019,32(03):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
　LIU Xian-feng,LI Zi-jun.Clinical Observation of Endo Combined with Pemetrexed and Cisplatin in the Treatment of Advanced Lung Adenocarcinoma[J].Journal of Medical Information,2019,32(23):148.[doi:10.3969/j.issn.1006-1959.2019.03.048]
[4]黄琪峰,郑琳琳,张 菁.生物信息学分析筛选肺腺癌靶基因及评估预后的价值[J].医学信息,2019,32(22):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
　HUANG Qi-feng,ZHENG Lin-lin,ZHANG Jing.Bioinformatics Analysis of Screening Lung Adenocarcinoma Target Genes and Evaluating Prognostic Value[J].Journal of Medical Information,2019,32(23):62.[doi:10.3969/j.issn.1006-1959.2019.22.020]
[5]唐怀慧,王忠帅,邵茜茜,等.基于TCGA数据库肺腺癌RNAs构建ceRNA网络的综合分析[J].医学信息,2020,33(07):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
　TANG Huai-hui,WANG Zhong-shuai,SHAO Qian-qian,et al.Comprehensive Analysis of Constructing ceRNA Network Based on TCGA Database of Lung Adenocarcinoma RNAs[J].Journal of Medical Information,2020,33(23):90.[doi:10.3969/j.issn.1006-1959.2020.07.025]
[6]莫俊贤,冼 磊.miRNA-21及PTEN在肺腺癌组织中的表达及意义[J].医学信息,2020,33(09):77.[doi:10.3969/j.issn.1006-1959.2020.09.022]
　MO Jun-xian,XIAN Lei.Expression and Significance of miRNA-21 and PTEN in Lung Adenocarcinoma[J].Journal of Medical Information,2020,33(23):77.[doi:10.3969/j.issn.1006-1959.2020.09.022]
[7]李 敖,王玉然,王文浩.基于公共数据库分析自噬相关基因在肺腺癌患者中的预后意义[J].医学信息,2022,35(22):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
　LI Ao,WANG Yu-ran,WANG Wen-hao.Prognostic Significance of Autophagy-related Genes in Patients with Lung Adenocarcinoma Based on Public Database Analysis[J].Journal of Medical Information,2022,35(23):17.[doi:10.3969/j.issn.1006-1959.2022.22.003]
[8]孔德伟,吴 铭,张 岩.肺腺癌骨转移肿瘤标记物的研究进展[J].医学信息,2022,35(23):171.[doi:10.3969/j.issn.1006-1959.2022.23.038]
　KONG De-wei,WU Ming,ZHANG Yan.Research Progress on Tumor Markers of Bone Metastasis in Lung Adenocarcinoma[J].Journal of Medical Information,2022,35(23):171.[doi:10.3969/j.issn.1006-1959.2022.23.038]
[9]思 璐,秦秋雯,沈 印,等.基于生物信息学分析筛选肺腺癌免疫预后相关lncRNA[J].医学信息,2023,36(01):1.[doi:10.3969/j.issn.1006-1959.2023.01.001]
　SI Lu,QIN Qiu-wen,SHEN Yin,et al.Screening of lncRNA Related to Immune Prognosis of Lung Adenocarcinoma Based on Bioinformatics Analysis[J].Journal of Medical Information,2023,36(23):1.[doi:10.3969/j.issn.1006-1959.2023.01.001]
[10]王 源,陈 丹,孙 建,等.基于数据库挖掘分析TPX2基因在肺腺癌中的表达及意义[J].医学信息,2023,36(01):24.[doi:10.3969/j.issn.1006-1959.2023.01.004]
　WANG Yuan,CHEN Dan,SUN Jian,et al.Analysis of the Expression and Significance of TPX2 Gene in Lung Adenocarcinoma Based on Database Mining[J].Journal of Medical Information,2023,36(23):24.[doi:10.3969/j.issn.1006-1959.2023.01.004]

更新日期/Last Update: 2018-12-17